InvestorsHub Logo
Followers 21
Posts 2542
Boards Moderated 0
Alias Born 12/07/2013

Re: jessellivermore post# 120660

Thursday, 01/11/2018 11:23:09 AM

Thursday, January 11, 2018 11:23:09 AM

Post# of 426486
Current sales of the drug are based upon marketing with the assumption that reducing trigs in 200- 500 range will reduce the number of cardiovascular events.

It is interesting that even when marketing the drug for that purpose the company isnt yet profitable .....

If REDUCE IT fails stock price implodes as most of the current usage is for trigs in the 200-500 range.


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News